Embio Profile
Key Indicators
- Authorised Capital ₹ 43.62 Cr
as on 24-10-2024
- Paid Up Capital ₹ 4.70 Cr
as on 24-10-2024
- Company Age 38 Year, 11 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 66.03 Cr
as on 24-10-2024
- Satisfied Charges ₹ 109.30 Cr
as on 24-10-2024
- Revenue 32.95%
(FY 2023)
- Profit -4.81%
(FY 2023)
- Ebitda -4.77%
(FY 2023)
- Net Worth 1.32%
(FY 2023)
- Total Assets 5.28%
(FY 2023)
About Embio
The Corporate was formerly known as Emmellen Biotech Pharmaceuticals Ltd. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 43.62 Cr and a paid-up capital of Rs 4.70 Cr.
The company currently has active open charges totaling ₹66.03 Cr. The company has closed loans amounting to ₹109.30 Cr, as per Ministry of Corporate Affairs (MCA) records.
The Key Managerial Personnel (KMP) at Embio Limited India is Ganesh Nalawade as COMPANY SECRETARY. Devesh Malladi, Ajit Vaswani, Madhusudan Garimella, and One other member serve as directors at the Company.
- CIN/LLPIN
U24110MH1986PLC038680
- Company No.
038680
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
20 Jan 1986
- Date of AGM
13 Aug 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Embio Limited offer?
Embio Limited offers a wide range of products and services, including Research and Development (R&D) Work, Product Development Research.
Who are the key members and board of directors at Embio?
Executive Team (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Devesh Malladi  | Managing Director | 01-Oct-2007 | Current |
| Ganesh Nalawade | Company Secretary | 13-Feb-2017 | Current |
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Madhusudan Garimella | Director | 07-Aug-2017 | Current |
| Ajit Vaswani | Director | 16-Oct-2001 | Current |
| Raghavachari Rangan | Director | 09-Oct-2024 | Current |
Financial Performance of Embio.
Embio Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 32.95% increase. The company also saw a slight decrease in profitability, with a 4.81% decrease in profit. The company's net worth moved up by a moderate rise of 1.32%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Embio?
In 2023, Embio had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Blinc Investment Management Private LimitedActive 4 years 4 monthsRaghavachari Rangan is a mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Axis Bank Limited Creation Date: 07 Mar 2022 | ₹25.00 Cr | Open |
Biotechnology Industry Research Assistance Council Creation Date: 10 Dec 2012 | ₹2.00 Cr | Open |
Axis Bank Limited Creation Date: 03 Dec 2002 | ₹25.00 Cr | Open |
How Many Employees Work at Embio?
Embio has a workforce of 600 employees as of Apr 05, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Embio, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Embio's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
